Literature DB >> 12853795

Diagnostic potential of serum proteomic patterns in prostate cancer.

Lionel L Bañez1, Premkala Prasanna, Leon Sun, Amina Ali, Zhiqiang Zou, Bao-Ling Adam, David G McLeod, Judd W Moul, Shiv Srivastava.   

Abstract

PURPOSE: The serum prostate specific antigen test has been widely used in the last decade as an effective screening tool for prostate cancer (CaP). However, the high false-positive rate of the serum prostate specific antigen test necessitates the development of more accurate diagnostic and prognostic biomarkers for CaP. Promising diagnostic potential of serum protein patterns detected by surface enhanced laser desorption/ionization time of flight mass spectrometry for CaP has recently been reported. Independent evaluation of this new technology is warranted to realize its translational utility. We determined whether serum protein profiling by surface enhanced laser desorption/ionization time of flight mass spectrometry and a decision tree algorithm classification system could accurately discriminate between patients with CaP and unaffected individuals.
MATERIALS AND METHODS: Proteomic spectra of crude serum were generated using the Ciphergen ProteinChip System and pattern detection was performed using Biomarker Patterns Software (Ciphergen Biosystems, Inc., Fremont, California). A total of 106 patients with CaP and 56 controls were randomly allocated to a training set and a test set. The training set, which consisted of 44 patients with cancer and 30 controls, was used to build a decision tree algorithm. The test set, which consisted of 62 patients with cancer and 26 controls, was used in blinded fashion to validate the decision tree.
RESULTS: Accuracy of classification using the test set was 67% and 42% for the weak cation exchange array and the copper metal affinity capture array, respectively. Combined spectral data from the weak cation exchange and copper metal affinity capture arrays generated an algorithm that achieved 85% sensitivity and 85% specificity for the detection of CaP.
CONCLUSIONS: These preliminary findings support recent observations that complex protein profiles have promising potential for the early detection of CaP and warrant future studies with streamlined technology. Furthermore, the combined effect of using 2 array types can greatly enhance the ability of protein profile patterns, suggesting the potential usefulness of alternative approaches to evaluate this new emerging technology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853795     DOI: 10.1097/01.ju.0000069431.95404.56

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  Prostate cancer detection strategies.

Authors:  Timothy C Brand; Javier Hernandez; Edith D Canby-Hagino; Joseph W Basler; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 3.092

2.  Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry.

Authors:  Karen Merrell; Katie Southwick; Steven W Graves; M Sean Esplin; Nathan E Lewis; Craig D Thulin
Journal:  J Biomol Tech       Date:  2004-12

3.  Formative evaluation of a prototype system for automated analysis of mass spectrometry data.

Authors:  N Fananapazir; M Li; D Spentzos; C F Aliferis
Journal:  AMIA Annu Symp Proc       Date:  2005

4.  Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.

Authors:  Pinar B Yildiz; Yu Shyr; Jamshedur S M Rahman; Noel R Wardwell; Lisa J Zimmerman; Bashar Shakhtour; William H Gray; Shuo Chen; Ming Li; Heinrich Roder; Daniel C Liebler; William L Bigbee; Jill M Siegfried; Joel L Weissfeld; Adriana L Gonzalez; Mathew Ninan; David H Johnson; David P Carbone; Richard M Caprioli; Pierre P Massion
Journal:  J Thorac Oncol       Date:  2007-10       Impact factor: 15.609

Review 5.  Mass spectrometry-based proteomic profiling of lung cancer.

Authors:  Sebahat Ocak; Pierre Chaurand; Pierre P Massion
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

6.  New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.

Authors:  Thomas Göbel; Sonja Vorderwülbecke; Katarzyna Hauck; Holger Fey; Dieter Häussinger; Andreas Erhardt
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 7.  Proteomic analysis in cancer research: potential application in clinical use.

Authors:  Jesús García-Foncillas; Eva Bandrés; Ruth Zárate; Natalia Remírez
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

Review 8.  Moving forward in colorectal cancer research, what proteomics has to tell.

Authors:  Nerea Bitarte; Eva Bandrés; Ruth Zárate; Natalia Ramirez; Jesus Garcia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  Establishment of a novel diagnostic model for Sjögren's syndrome by proteomic fingerprinting.

Authors:  Yuhui Li; Xiaolin Sun; Xuewu Zhang; Yuqin Yang; Rulin Jia; Xu Liu; Ru Li; Yanying Liu; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2014-09-02       Impact factor: 2.980

10.  Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.

Authors:  Qi Wang; Jing Shen; Zhen-fu Li; Jian-zheng Jie; Wen-yue Wang; Jin Wang; Zhong-tao Zhang; Zhi-xia Li; Li Yan; Jin Gu
Journal:  BMC Cancer       Date:  2009-08-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.